Finally, and perhaps most significantly, the Court considered the Tamoxifen decision to have been based on an unambiguous mischaracterization of the law, specifically that the 180 day exclusivity period would be ceded by the first ANDA filer upon entering into a reverse payment containing settlement of ANDA litigation <a href=http://lasix.autos/>cost of lasix</a>